In line with our results, AKR1C1-3 were reported to induce resistance to cisplatin in colon cancer36 and to repress the sensitivity to ATRA-induced differentiation37 or bezafibrate26 in AML. This evidence concerns the gene AKR1C1 and acute myeloid leukemia.